Treating coronavirus infection with azithromycin doesn’t seem to make sense, new research says.
The antibiotic azithromycin, which is prescribed to patients with coronavirus, does not improve their condition. When treating COVID-19, it is better to completely abandon this drug until the bacteria become addicted to it.
Earlier, virologists from France stated that azithromycin helps in the treatment of coronavirus, and the combination of azithromycin and the antimalarial agent hydroxychloroquine significantly reduces the severity of COVID-19.
- This much coffee raises your risk of dementia
- Doctor explains what people can do to stay safe as Delta variant cases rise
- This is how leaky calcium puts epileptics at heart risk
- A protein that keeps the immune system from going crazy could lead to new treatments
- Delta Variant’s Severe Dangers, Even for Fully Vaccinated – Report
Scientists from the University of California at San Francisco with scientists from Stanford University conducted a study and found that the use of azithromycin by COVID patients did not reduce their risk of entering intensive care or death from infection.
“It is important that doctors around the world in the near future stop using this drug to fight COVID-19, which will reduce the risk that bacteria will begin to acquire resistance to its action,” American and British experts say.
They conducted a study involving 298 people who were diagnosed with the coronavirus.
Patients with mild to moderate forms of the disease taking high doses of azithromycin did not improve their condition.
In severely ill patients, the antibiotic did not reduce their likelihood of being admitted to intensive care.
Photo by Dimitar DILKOFF / AFP) (Photo by DIMITAR DILKOFF/AFP via Getty Images